Formal discussion: the clinical pharmacology of anti-leukemia agents.
D000813:Anilides / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D014520:Urethane / Q000627:therapeutic use*; D014750:Vincristine / Q000008:administration & dosage*
D000813:Anilides; D014520:Urethane; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate